BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8549352)

  • 1. Stereoselectivity of ofloxacin intestinal transport in the rat.
    Rabbaa L; Dautrey S; Colas-Linhart N; Carbon C; Farinotti R
    Drugs; 1995; 49 Suppl 2():333-4. PubMed ID: 8549352
    [No Abstract]   [Full Text] [Related]  

  • 2. Intestinal elimination of ofloxacin enantiomers in the rat: evidence of a carrier-mediated process.
    Rabbaa L; Dautrey S; Colas-Linhart N; Carbon C; Farinotti R
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2126-30. PubMed ID: 8878593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption of ofloxacin isomers in the rat small intestine.
    Rabbaa L; Dautrey S; Colas-Linhart N; Carbon C; Farinotti R
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2274-7. PubMed ID: 9333061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Excretion of fluoroquinolones into saliva].
    Kelentey BA; Kelentey BJ; Fekete I; Kozma J
    Fogorv Sz; 1995 Sep; 88(9):293-7. PubMed ID: 8522025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetic properties of ofloxacin (review of the literature].
    Iakovlev VP
    Antibiot Khimioter; 1996; 41(9):24-32. PubMed ID: 9005781
    [No Abstract]   [Full Text] [Related]  

  • 6. Kinetic mechanism for the intestinal absorption of ofloxacin.
    Prieto JG; Barrio JP; Alvarez AI; Gómez G
    J Pharm Pharmacol; 1988 Mar; 40(3):211-2. PubMed ID: 2899154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetics of fluoroquinolones].
    Iakovlev VP
    Antibiot Khimioter; 1993 Jun; 38(6):66-78. PubMed ID: 8166571
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of fluoroquinolones in hepatic failure.
    Montay G; Gaillot J
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():61-7. PubMed ID: 2258353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of 4-fluoroquinolones permeation into saliva.
    Kozjek F; Suturkova LJ; Antolic G; Grabnar I; Mrhar A
    Biopharm Drug Dispos; 1999 May; 20(4):183-91. PubMed ID: 10440793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of probenecid and cimetidine on renal disposition of ofloxacin in rats.
    Foote EF; Halstenson CE
    Antimicrob Agents Chemother; 1998 Feb; 42(2):456-8. PubMed ID: 9527807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption of topically administered ciprofloxacin, ofloxacin and gentamicin in the inflamed rabbit eye.
    Behrens-Baumann W
    Ophthalmologica; 1996; 210(2):119-22. PubMed ID: 8859488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carrier-mediated system for pefloxacin uptake in human monocytes.
    Mémin E; Panteix G; Revol A
    J Antimicrob Chemother; 1997 Aug; 40(2):263-8. PubMed ID: 9301993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemotherapy activity and pharmacokinetics of the fluoroquinolones generics Ofloxacin-PhPO and Pefloxacin-genova].
    Ptitsina SN; Bobrov VI; Borisov MM
    Antibiot Khimioter; 2007; 52(6):13-6. PubMed ID: 18476469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetic basis for the use of pefloxacin in severe forms of infectious-inflammatory diseases].
    Navashin PS; Smirnova LB
    Antibiot Khimioter; 1998; 43(12):30-8. PubMed ID: 10079873
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative pharmacokinetics of new quinolones.
    Lode H; Höffken G; Prinzing C; Glatzel P; Wiley R; Olschewski P; Sievers B; Reimnitz D; Borner K; Koeppe P
    Drugs; 1987; 34 Suppl 1():21-5. PubMed ID: 3481323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aqueous humour levels of topically applied ciprofloxacin and ofloxacin in the same subjects.
    Cekiç O; Batman C; Totan Y; Yasar U; Basci NE; Bozkurt A; Kayaalp SO; Zilelioglu O
    Eye (Lond); 1999 Oct; 13 ( Pt 5)():656-9. PubMed ID: 10696321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of effect of ketoprofen on the pharmacokinetics of pefloxacin and ofloxacin.
    Fillastre JP; Leroy A; Borsa-Lebas F; Etienne I; Gy C; Humbert G
    J Antimicrob Chemother; 1993 May; 31(5):805-6. PubMed ID: 8335511
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantification of the enantiomers of ofloxacin in biological fluids by high-performance liquid chromatography.
    Lehr KH; Damm P
    J Chromatogr; 1988 Mar; 425(1):153-61. PubMed ID: 3162915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transformation of S- (+)-ofloxacin enantiomer in human body and determination by synchronous-derivative fluorimetry].
    Gong QJ; Jin WJ; Dong C
    Guang Pu Xue Yu Guang Pu Fen Xi; 2001 Oct; 21(5):688-90. PubMed ID: 12945333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic studies in rats with ofloxacin and MF-934, a new fluorinated quinolone.
    Mattina R; Bellotti M; Raimondi A; Sander K
    Chemioterapia; 1987 Jun; 6(2 Suppl):302-3. PubMed ID: 3334569
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.